Loading...

BKYI BIO KEY INTERNATIONAL INC Capital Structure Changes 8-K Filing

B KY

BKY

BIO KEY INTERNATIONAL INC

(BKYI)

2025 8-K

Financial Results Update

Financial Results Report

Financial Results Released

Nasdaq Listing Update

Warrant Agreement Details

New Loan Agreement

Share Plan Amendments

Annual Meeting Results

Q2 Financial Results

Notice of Delisting

Notice of Delisting

Financial Results

Warrant Exercise Agreement

Compliance Regained

Stock Acquisition

Q3 Earnings Report

Warrant Exercise Agreement

Annual Meeting Results

Q2 Earnings Report

Financial Results Announcement

Delisting Notice

Delisting Notice

Changes in Registrant's Cer...

Financial Results Announcement

Compliance with Bid Price Rule

Private Placement

Stock Incentive Plan and Re...

Resignation of Director

Securities Purchase Agreeme...

Financial Results Announcement

Earnings Report

Annual Meeting of Stockholders

Agreement Amendment

Compliance with Listing Rule

Appointment of Director

Delisting Notice

Financial Results Announcement

Delisting Notice

Resignation of Director

Financial Results Announcement

Resignation of Director

External Links:

On October 27, 2025, BIO-key International Inc. entered into a warrant exercise agreement to exercise 3,091,668 shares at a reduced price of $1.02 per share, raising approximately $3.1 million for working capital.

AI Assistant

BIO KEY INTERNATIONAL INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.